2017-2022 United States Osteoporosis Drugs Market Report (Status and Outlook)

June 2017 | 111 pages | ID: 21739ECD7DBEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Osteoporosis Drugs market size will be XX million (USD) in 2022 in United States, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.

In United States market, the top players include

• Eli Lilly
• Novartis
• Pfizer
• Amgen
• Merck
• Novo nordisk
• Actavis
• Roche

This report with sales, revenue and market share for each type, split by product types/category, covering

• Antiresorptive Drugs
• Anabolic Drugs

This report focuses on sales, market share and growth rate of Osteoporosis Drugs in each application, split by applications/end use industries, covers

• Male
• Female

Contents

2017-2022 UNITED STATES OSTEOPOROSIS DRUGS MARKET REPORT (STATUS AND OUTLOOK)

1 OSTEOPOROSIS DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Osteoporosis Drugs
1.2 Osteoporosis Drugs Market Segment by Types
  1.2.1 United States Osteoporosis Drugs Sales Present Situation and Outlook by Types (2012-2022)
  1.2.2 United States Osteoporosis Drugs Sales Market Share by Types in 2016
  1.2.3 Antiresorptive Drugs
Anabolic Drugs
1.3 United States Osteoporosis Drugs Market Segment by Applications/End Use Industries
  1.3.1 United States Osteoporosis Drugs Sales Present Situation and Outlook by Applications/End Industrials (2012-2022)
  1.3.2 United States Osteoporosis Drugs Sales Market Share by Applications/End Industrials in 2016
  1.3.3 Male
Female
1.4 United States Osteoporosis Drugs Overview and Market Size (Value) (2012-2022)
  1.4.1 United States Market Osteoporosis Drugs Overview
  1.4.2 United States Osteoporosis Drugs Market Size (Value and Volume) Status and Forecast (2012-2022)

2 UNITED STATES OSTEOPOROSIS DRUGS SALES, REVENUE (VALUE) AND MARKET SHARE BY PLAYERS/MANUFACTURERS

2.1 United States Osteoporosis Drugs Sales and Market Share (2012-2017) by Vendors/Manufacturers
2.2 United States Osteoporosis Drugs Revenue and Market Share by Vendors (2012-2017)
2.3 United States Osteoporosis Drugs Average Price by Vendors in 2016
2.4 United States Osteoporosis Drugs Manufacturing Base Distribution, Sales Area, Product Types by Vendors
2.5 Osteoporosis Drugs Market Competitive Situation and Trends
  2.5.1 Osteoporosis Drugs Market Concentration Rate
  2.5.2 Osteoporosis Drugs Market Share of Top 3 and Top 5 Vendors
  2.5.3 Mergers & Acquisitions, Expansion

3 UNITED STATES OSTEOPOROSIS DRUGS SALES, REVENUE (VALUE) BY TYPE AND APPLICATION (2012-2017)

3.1 United States Osteoporosis Drugs Sales, Revenue, Market Share and Price by Type (2012-2017)
  3.1.1 United States Osteoporosis Drugs Sales and Market Share by Type (2012-2017)
  3.1.2 United States Osteoporosis Drugs Revenue and Market Share by Type (2012-2017)
  3.1.3 United States Osteoporosis Drugs Price by Type (2012-2017)
3.2 United States Osteoporosis Drugs Sales and Market Share by Application (2012-2017)
3.3 United States Market Osteoporosis Drugs Sales, Revenue (Million USD), Price and Gross Margin (2012-2017)

4 UNITED STATES OSTEOPOROSIS DRUGS VENDORS/MANUFACTURERS PROFILES AND SALES DATA

4.1 Eli Lilly
  4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.1.2 Osteoporosis Drugs Product Types, Application and Specification
    4.1.2.1 Type
    4.1.2.2 Type
  4.1.3 Eli Lilly Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.1.4 Main Business/Business Overview
4.2 Novartis
  4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.2.2 Osteoporosis Drugs Product Types, Application and Specification
    4.2.2.1 Type
    4.2.2.2 Type
  4.2.3 Novartis Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.2.4 Main Business/Business Overview
4.3 Pfizer
  4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.3.2 Osteoporosis Drugs Product Types, Application and Specification
    4.3.2.1 Type
    4.3.2.2 Type
  4.3.3 Pfizer Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.3.4 Main Business/Business Overview
4.4 Amgen
  4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.4.2 Osteoporosis Drugs Product Types, Application and Specification
    4.4.2.1 Type
    4.4.2.2 Type
  4.4.3 Amgen Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.4.4 Main Business/Business Overview
4.5 Merck
  4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.5.2 Osteoporosis Drugs Product Types, Application and Specification
    4.5.2.1 Type
    4.5.2.2 Type
  4.5.3 Merck Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.5.4 Main Business/Business Overview
4.6 Novo nordisk
  4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.6.2 Osteoporosis Drugs Product Types, Application and Specification
    4.6.2.1 Type
    4.6.2.2 Type
  4.6.3 Novo nordisk Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.6.4 Main Business/Business Overview
4.7 Actavis
  4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.7.2 Osteoporosis Drugs Product Types, Application and Specification
    4.7.2.1 Type
    4.7.2.2 Type
  4.7.3 Actavis Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.7.4 Main Business/Business Overview
4.8 Roche
  4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.8.2 Osteoporosis Drugs Product Types, Application and Specification
    4.8.2.1 Type
    4.8.2.2 Type
  4.8.3 Roche Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.8.4 Main Business/Business Overview

5 PRODUCTION COST ANALYSIS OF OSTEOPOROSIS DRUGS

5.1 Main Raw Materials of Osteoporosis Drugs
  5.1.1 List of Osteoporosis Drugs Main Raw Materials
  5.1.2 Osteoporosis Drugs Main Raw Materials Price Analysis
  5.1.3 Osteoporosis Drugs Raw Materials Major Suppliers
  5.1.4 Osteoporosis Drugs Main Raw Materials Market Concentration Rate
5.2 Production Cost Structure of Osteoporosis Drugs
  5.2.1 Raw Materials
  5.2.2 Labor Cost
  5.2.3 Production Expenses
5.3 Osteoporosis Drugs Manufacturing Process/Method

6 VALUE CHAIN, PURCHASING STRATEGY AND DOWNSTREAM BUYERS

6.1 Osteoporosis Drugs Value Chain Analysis
6.2 Upstream Raw Materials Purchasing
6.3 Raw Materials Sources of Osteoporosis Drugs Major Vendors in 2016
6.4 Downstream Buyers

7 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

7.1 Sales Channel
  7.1.1 Direct Sales
  7.1.2 Indirect Sales
  7.1.3 Sales Channel Development Trend
7.2 Product Market Positioning
  7.2.1 Pricing Strategy
  7.2.2 Brand Strategy
  7.2.3 Target Client
7.3 Osteoporosis Drugs Distributors/Traders List in United States

8 MARKET INFLUENCES FACTORS ANALYSIS

8.1 Changes from the Related Industries
8.2 Substitutes Threat
8.3 Customer Preference Change
8.4 Economic/Political Environmental Change
8.5 Upstream and Downstream Fluctuation

9 UNITED STATES OSTEOPOROSIS DRUGS MARKET FORECAST (2017-2022)

9.1 United States Osteoporosis Drugs Sales, Revenue and Price Forecast (2017-2022)
  9.1.1 United States Osteoporosis Drugs Sales and Growth Rate Forecast (2017-2022)
  9.1.2 United States Osteoporosis Drugs Revenue and Growth Rate Forecast (2017-2022)
  9.1.3 United States Osteoporosis Drugs Price Trend Forecast (2017-2022)
9.2 United States Osteoporosis Drugs Sales Forecast by Type (2017-2022)
9.3 United States Osteoporosis Drugs Sales Forecast by Application (2017-2022)

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Osteoporosis Drugs
Table Product Specifications of Osteoporosis Drugs
Figure United States Osteoporosis Drugs Sales (volume) for Each Type (2012-2022)
Figure United States Osteoporosis Drugs Sales Market Share by Types in 2016
Table Types of Osteoporosis Drugs
Figure Product Picture of Antiresorptive Drugs
Table Major Players of Antiresorptive Drugs
Figure Product Picture of Anabolic Drugs
Table Major Players of Anabolic Drugs
Figure United States Osteoporosis Drugs Sales Present Situation and Outlook by Applications (2012-2022)
Figure United States Osteoporosis Drugs Sales Market Share by Applications/End Industrials in 2016
Table Applications of Osteoporosis Drugs
Figure Male Examples
Figure Female Examples
Figure United States Osteoporosis Drugs Revenue (Million USD) Status and Forecast (2012-2022)
Figure United States Osteoporosis Drugs Sales (Volume) Status and Forecast (2012-2022)
Table United States Osteoporosis Drugs Sales by Vendors (2012-2017)
Table United States Osteoporosis Drugs Sales Market Share (%) by Vendors (2012-2017)
Figure United States Osteoporosis Drugs Sales Share by Vendors in 2016
Figure United States Osteoporosis Drugs Sales Share by Vendors in 2017
Table United States Osteoporosis Drugs Revenue (Million USD) by Vendors (2012-2017)
Table United States Osteoporosis Drugs Revenue Market Share (%) by Vendors (2012-2017)
Figure United States Osteoporosis Drugs Revenue Share by Vendors in 2016
Figure United States Osteoporosis Drugs Revenue Share by Vendors in 2017
Figure United States Osteoporosis Drugs Average Price by Vendors in 2016
Table United States Osteoporosis Drugs Manufacturing Base Distribution and Sales Area by Vendors
Table Vendors Osteoporosis Drugs Product Types
Figure Osteoporosis Drugs Market Share of Top 3 Vendors
Figure Osteoporosis Drugs Market Share of Top 5 Vendors
Table United States Osteoporosis Drugs Sales by Type (2012-2017)
Table United States Osteoporosis Drugs Sales and Market Share by Type (2012-2017)
Figure United States Osteoporosis Drugs Sales Market Share by Type 2016
Figure 2016 United States Osteoporosis Drugs Sales Market Share by Type
Table United States Osteoporosis Drugs Revenue (Million USD) by Type (2012-2017)
Table United States Osteoporosis Drugs Revenue Market Share by Type (2012-2017)
Figure United States Osteoporosis Drugs Revenue Market Share by Type 2016
Figure 2016 United States Osteoporosis Drugs Revenue Market Share by Type
Table United States Osteoporosis Drugs Price by Type (2012-2017)
Table United States Osteoporosis Drugs Sales by Application (2012-2017)
Table United States Osteoporosis Drugs Sales and Market Share by Application (2012-2017)
Figure United States Osteoporosis Drugs Sales Market Share by Application (2012-2017)
Figure 2016 United States Osteoporosis Drugs Sales Market Share by Application
Table United States Market Osteoporosis Drugs Sales, Revenue (Million USD), Price and Gross Margin (2012-2017)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lilly Osteoporosis Drugs Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Osteoporosis Drugs Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Osteoporosis Drugs Market Share (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Osteoporosis Drugs Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Osteoporosis Drugs Market Share (2012-2017)
Table Novo nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo nordisk Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novo nordisk Osteoporosis Drugs Market Share (2012-2017)
Table Actavis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Actavis Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Actavis Osteoporosis Drugs Market Share (2012-2017)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Osteoporosis Drugs Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Osteoporosis Drugs Main Raw Materials Price Trend
Table Osteoporosis Drugs Raw Materials Major Suppliers List
Figure Production Cost Structure of Osteoporosis Drugs
Figure Osteoporosis Drugs Manufacturing Process/Method
Figure Osteoporosis Drugs Value Chain Analysis
Table Raw Materials Sources of Osteoporosis Drugs Major Vendors in 2016
Table Major Buyers of Osteoporosis Drugs
Table Osteoporosis Drugs Distributors/Traders List in United States
Figure United States Osteoporosis Drugs Sales and Growth Rate Forecast (2017-2022)
Figure United States Osteoporosis Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure United States Osteoporosis Drugs Price Trend Forecast (2017-2022)
Table United States Osteoporosis Drugs Sales Forecast by Type (2017-2022)
Figure United States Osteoporosis Drugs Sales Market Share Forecast by Type (2017-2022)
Figure United States Osteoporosis Drugs Sales Market Share Forecast by Type in 2022
Table United States Osteoporosis Drugs Sales Forecast by Application (2017-2022)
Figure United States Osteoporosis Drugs Sales Market Share Forecast by Application (2017-2022)
Figure United States Osteoporosis Drugs Sales Market Share Forecast by Application in 2022